Cargando…
Tumor Necrosis Factor Receptor Associated Factor 6 Is Not Required for Atherogenesis in Mice and Does Not Associate with Atherosclerosis in Humans
BACKGROUND: Tumor necrosis factor receptor-associated factors (TRAFs) are important signaling molecules for a variety of pro-atherogenic cytokines including CD40L, TNF α, and IL1β. Several lines of evidence identified TRAF6 as a pro-inflammatory signaling molecule in vitro and we previously demonstr...
Autores principales: | Stachon, Peter, Missiou, Anna, Walter, Carina, Varo, Nerea, Colberg, Christian, Wolf, Dennis, Buchner, Maike, von zur Mühlen, Constantin, Zirlik, Katja, Bode, Christoph, Zirlik, Andreas |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2904388/ https://www.ncbi.nlm.nih.gov/pubmed/20644648 http://dx.doi.org/10.1371/journal.pone.0011589 |
Ejemplares similares
-
Cannabinoid Receptor 2 Signaling Does Not Modulate Atherogenesis in Mice
por: Willecke, Florian, et al.
Publicado: (2011) -
Risk‐Adjusted Comparison of In‐Hospital Outcomes of Transcatheter and Surgical Aortic Valve Replacement
por: Stachon, Peter, et al.
Publicado: (2019) -
The Role of Tumor Necrosis Factor Associated Factors (TRAFs) in Vascular Inflammation and Atherosclerosis
por: Gissler, Mark Colin, et al.
Publicado: (2022) -
Coronary artery bypass grafting versus stent implantation in patients with chronic coronary syndrome and left main disease: insights from a register throughout Germany
por: Stachon, Peter, et al.
Publicado: (2021) -
Mac-1 Directly Binds to the Endothelial Protein C-Receptor: A Link between the Protein C Anticoagulant Pathway and Inflammation?
por: Fink, Katrin, et al.
Publicado: (2013)